ChemTrak Inc. said that it has licensed worldwide, non-exclusive rights to technology from nine Syva Co. patents inexchange for a licensing fee and future royalties.
The patents cover technology related to development of assaysusing solid support chemistry, which permits development ofself-contained test products, according to ChemTrak(NASDAQ:CMTR) of Sunnyvale, Calif.
The current agreement amends an earlier licensing agreementunder which Syva, the diagnostic subsidiary of Syntex Corp.,licensed patents covering ChemTrak's AccuMeter cholesteroltest.
(c) 1997 American Health Consultants. All rights reserved.